AssAssertio Holdings Inc (ASRT): REDWOOD CITY, Calif., Dec. 03, 2024 (GLO...

Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	358
Boards Moderated	0
Alias Born	12/21/2022

dcaf7

Re: None

Thursday, 12/05/2024 9:18:56 AM

Thursday, December 05, 2024 9:18:56 AM

REDWOOD CITY, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus or the Company NASDAQ: CHRS,) today announced that it has entered into an asset purchase agreement (the Agreement) dated December 2, 2024, with Intas Pharmaceuticals Ltd. (Intas) for the divestiture of the UDENYCA (pegfilgrastim-cbqv) franchise for up to $558.4 million.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ASRT News

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2026 08:11:08 PM
Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 05/08/2026 12:15:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 12:13:05 PM
Assertio and Garda Mutually Agree to Delay Launch of Tender Offer • Business Wire • 05/08/2026 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 09:00:25 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 10:05:09 PM
Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 05/05/2026 01:09:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 01:07:36 PM
Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer • Business Wire • 05/05/2026 01:00:00 PM
Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 05/04/2026 12:26:40 PM
Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 05/04/2026 12:23:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 12:21:04 PM
Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics • Business Wire • 05/04/2026 12:00:00 PM
Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 04/29/2026 09:08:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 09:07:22 PM
Assertio and Garda Mutually Agree to Extend Tender Offer Deadline • Business Wire • 04/29/2026 08:30:00 PM
Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 04/21/2026 09:15:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/21/2026 09:15:20 PM
Assertio Provides Update on Garda Therapeutics Tender Process • Business Wire • 04/21/2026 09:00:00 PM
Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 04/14/2026 09:09:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 08:41:12 PM
Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 04/09/2026 09:24:04 PM
Form SC TO-C - Written communication relating to an issuer or third party • Edgar (US Regulatory) • 04/09/2026 09:16:11 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/09/2026 09:15:20 PM
Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 04/09/2026 12:11:45 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent ASRT News

More ASRT News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent ASRT News

Go Ad-Free